329 related articles for article (PubMed ID: 542924)
1. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
Loeliger EA; van Halem-Visser LP
Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
[No Abstract] [Full Text] [Related]
2. Standardization of laboratory tests for controlling anticoagulent therapy.
Zucker S; Cathey MH; Sox PJ; Hall EC
Am J Clin Pathol; 1970 Mar; 53(3):348-54. PubMed ID: 5416772
[No Abstract] [Full Text] [Related]
3. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of human blood coagulation elicited by thrombin.
Marciniak E
J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
[No Abstract] [Full Text] [Related]
5. Prothrombin time standardization: report of the expert panel on oral anticoagulant control. The International Committee on Thrombosis and Haemostasis, The International Committee for Standardization in Hematology.
Thromb Haemost; 1979 Dec; 42(4):1073-114. PubMed ID: 542923
[TBL] [Abstract][Full Text] [Related]
6. Stability of freeze-dried plasma prepared from patients on oral anticoagulants.
Brozović M; Howarth DJ; van Halem Visser LP; Loeliger EA
J Clin Pathol; 1973 Nov; 26(11):857-63. PubMed ID: 4797328
[TBL] [Abstract][Full Text] [Related]
7. Results of calibration by the Dutch National Reference Laboratory of the thromboplastins included in the ICTH/ICSH collaborative study of prothrombin time standardization.
Loeliger EA; van Halem-Visser LP
Thromb Haemost; 1979 Dec; 42(4):1128-31. PubMed ID: 542925
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity of various thromboplastins in different animal species.
Mifsud CV
Pharmacol Ther B; 1979; 5(1-3):251-6. PubMed ID: 115016
[No Abstract] [Full Text] [Related]
9. Prothrombin time standardization report of the expert panel on oral anticoagulant control: a minority opinion.
Miale JB
Thromb Haemost; 1979 Dec; 42(4):1132-4. PubMed ID: 542926
[TBL] [Abstract][Full Text] [Related]
10. Prothrombin utilization in congenital coagulation deficiency states.
Owen CA; Thompson JH
Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
[No Abstract] [Full Text] [Related]
11. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
Kolde HJ
Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
[No Abstract] [Full Text] [Related]
12. [Sensitivity of several commercial thromboplastins to non-carboxylated clotting factors II and X (author's transl)].
Averdunk R; Grüner J
J Clin Chem Clin Biochem; 1981 Feb; 19(2):89-97. PubMed ID: 7217898
[TBL] [Abstract][Full Text] [Related]
13. Dilution curve studies in prothrombin complex factors deficiencies and abnormalities.
Girolami A; Brunetti A; DeMarco L; Fioretti D
Blut; 1974 Aug; 29(2):134-43. PubMed ID: 4851393
[No Abstract] [Full Text] [Related]
14. Preparation of canine factor VII deficient substrate plasma.
Gaston LW; Spivack AR
J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
[No Abstract] [Full Text] [Related]
15. Prothrombin level in coumarin-treated patients. A peculiar effect observed in a one-stage system using certain substrates.
Girolami A; Bareggi G; Cella G; Patrassi G
Am J Clin Pathol; 1974 May; 61(5):654-61. PubMed ID: 4857077
[No Abstract] [Full Text] [Related]
16. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
Pineo GF; Regoeczi E; Hatton MW; Brain MC
J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814
[No Abstract] [Full Text] [Related]
17. Standardization of thromboplastin reagents and control plasmas.
Owren PA
Haematologia (Budap); 1974; 8(1-4):441-54. PubMed ID: 4461430
[No Abstract] [Full Text] [Related]
18. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
Hjorth B; Kjaersgaard E
Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
[TBL] [Abstract][Full Text] [Related]
19. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
[No Abstract] [Full Text] [Related]
20. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
Girolami A; Scandellari R; Scapin M; Vettore S
Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
